Replication of low-copy-number iteron plasmids is tightly controlled by initiator proteins that coordinate replication initiation with transcriptional autoregulation. In the F-plasmid system, RepE fulfills both functions through a balance between monomeric and dimeric forms. Here, random mutagenesis of the repE gene combined with high-stringency selection was used to identify variants that modulate plasmid copy number. Two point mutations, A78S and Q45L, were identified and shown by qPCR and ddPCR to increase the copy number of plasmid pFO1 relative to the parental repE(R118P) allele. The mutations exhibited growth-phase-dependent effects, with A78S having a stronger impact during exponential growth and Q45L during stationary phase. A double mutant showed a cumulative effect, particularly in exponential phase. RepE transcription increased in the presence of pFO1 and correlated with plasmid copy number, supporting a titration-based regulatory model. These findings demonstrate that engineering RepE variants enables tunable control of plasmid copy number, offering a useful strategy for optimizing gene dosage in synthetic biology and biotechnological applications. Key points • RepE variants enable fi ne-tuning of plasmid copy number. • Gene dosage can be modulated without changing plasmid architecture. • RepE engineering off ers potential applications in biotechnology.
No takes yet. Share an insight, caveat, or question.
Ján Krahulec (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: